George Clinical, a leading Asia-Pacific CRO, is wholly owned by The George Institute, a world leading medical research institute focused on chronic disease. Our model sees us forming integrated project teams with our scientific thought leaders.
The Neurological & Mental Health unit, one of the many divisions within The George Institute, has led many clinical trials in stroke where George Clinical was responsible for operational implementation. This video below discusses one of our landmark studies, INTERACT2, and its impact on future treatment of intracerebral hemorrhage (ICH).
Click here to see more information about our global stroke network